Results 211 to 220 of about 87,208 (292)

Pathologic complete response in rectal cancer: advocating for local excision. [PDF]

open access: yesAnn Coloproctol
Gonzalez-Nunez D   +3 more
europepmc   +1 more source

Survival Benefit of Adjuvant Radiotherapy After Surgery in Patients With T1‐2N1M0 Hypopharyngeal Squamous Cell Carcinoma: A Dual‐Cohort Analysis of SEER and Institutional Data

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background The optimal therapeutic strategy for patients with T2‐3N0‐3 M0 or T1N1‐3 M0 hypopharyngeal squamous cell carcinoma (HPSCC) and the use of postoperative radiotherapy with or without systemic therapy for patients with T1‐2N1M0 HPSCC remain controversial.
Zhangwei Hu   +8 more
wiley   +1 more source

Outcomes and recurrence pattern analysis of intensity modulated chemoradiotherapy in nasopharyngeal cancer: a retrospective study from Heidelberg University Hospital. [PDF]

open access: yesRadiat Oncol
Bauer L   +11 more
europepmc   +1 more source

Additional file 1: of Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma

open access: gold, 2019
Sehhoon Park   +12 more
openalex   +1 more source

Identification of Glioma Phenotypic Subtypes From Multimodal MRI Data Using Hierarchical Multi‐Kernel Learning

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
Our study identified glioma phenotypic subtypes based on T1CE and T2FLAIR radiomic features, along with associated pathway activities, providing real‐time insights into tumor dynamics to guide preoperative clinical decision‐making and improve patient management.
Junyu Yan   +9 more
wiley   +1 more source

Carcinosarcoma of the Parotid With Osteosarcoma Component: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Carcinosarcomas of the salivary gland with osteosarcoma component are very rare, with only 17 cases reported. Despite multiple poor prognostic factors, our patient's outcome was favorable, highlighting the importance of early diagnosis and aggressive treatment in improving prognosis for this aggressive tumor variant.
Shubham Dokania   +8 more
wiley   +1 more source

Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial. [PDF]

open access: yesNat Commun
Zheng X   +15 more
europepmc   +1 more source

231P: Prognostic factors for survival in unresectable stage III non-small cell lung cancer (NSCLC) receiving chemoradiotherapy (CRT) [PDF]

open access: bronze
Jie Zhou   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy